Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1996 Oct;34(10):2569–2571. doi: 10.1128/jcm.34.10.2569-2571.1996

Patterns of detection of Strongyloides stercoralis in stool specimens: implications for diagnosis and clinical trials.

G Dreyer 1, E Fernandes-Silva 1, S Alves 1, A Rocha 1, R Albuquerque 1, D Addiss 1
PMCID: PMC229319  PMID: 8880521

Abstract

Reported efficacies of drugs used to treat Strongyloides stercoralis infection vary widely. Because diagnostic methods are insensitive, therapeutic trials generally require multiple negative posttreatment stool specimens as evidence of drug efficacy. However, only a single positive stool specimen is usually required for study enrollment. To determine the reproducibility of detection of S. stercoralis larvae in the stool, 108 asymptomatic infected men submitted 25 g of fresh stool once a week for eight consecutive weeks for examination by the Baermann technique. During the 8-week study, 239 (27.7%) of 864 stool specimens were positive for S. stercoralis. Rates of detection of larvae in the stool specimens ranged from eight of eight specimens in 3 (2.8%) men to none of eight specimens in 36 (33.3%) men. Of 43 men for whom S. stercoralis was detected in at least two of the first four stool specimens, only 1 (2.3%) man tested negative on all of the next four specimens. In comparison, of 29 men who had detectable larvae in only one of the first four specimens, 22 (75.9%) tested negative on all of the next four samples. Thus, if these 29 men had been enrolled in a therapeutic trial between the first and second sets of four specimens, the efficacy of a drug with no activity against this parasite would have been estimated to be 76%. These data suggest that patterns of S. stercoralis detection vary widely among infected persons and that intermittent larval shedding can lead to inflated estimates of drug efficacy. Before a patient is entered in a clinical trial of drug efficacy, four consecutive stool specimens should be examined for S. stercoralis; only persons with two or more positive specimens should be enrolled.

Full Text

The Full Text of this article is available as a PDF (159.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aca I. da S., Kobayashi S., Carvalho Júnior L. B., Tateno S., Takeuchi T. Prevalence and pathogenicity of Entamoeba histolytica in three different regions of Pernambuco, northeast Brazil. Rev Inst Med Trop Sao Paulo. 1994 Nov-Dec;36(6):519–524. doi: 10.1590/s0036-46651994000600008. [DOI] [PubMed] [Google Scholar]
  2. Amato Neto V., Sinto T., Pedro R. J., Levi G. C., Tsukumo M. K., Moraes V. M., Corrêa L. L. Nossas observaçes iniciais sobre a eficácia do cambendazole no tratamento da estrongiloidiase. Rev Inst Med Trop Sao Paulo. 1978 May-Jun;20(3):161–163. [PubMed] [Google Scholar]
  3. Baranski M. C., da Silva A. F., Kotaka P. I., Gomes N. R., Giovannoni M., Telles J. E. Tratamento da estrongiloidíase humana com novo anti-helmíntico, o cambendazole. Estudo duplo cego. Rev Inst Med Trop Sao Paulo. 1978 Jul-Aug;20(4):213–218. [PubMed] [Google Scholar]
  4. Conway D. J., Atkins N. S., Lillywhite J. E., Bailey J. W., Robinson R. D., Lindo J. F., Bundy D. A., Bianco A. E. Immunodiagnosis of Strongyloides stercoralis infection: a method for increasing the specificity of the indirect ELISA. Trans R Soc Trop Med Hyg. 1993 Mar-Apr;87(2):173–176. doi: 10.1016/0035-9203(93)90477-8. [DOI] [PubMed] [Google Scholar]
  5. Gann P. H., Neva F. A., Gam A. A. A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis. J Infect Dis. 1994 May;169(5):1076–1079. doi: 10.1093/infdis/169.5.1076. [DOI] [PubMed] [Google Scholar]
  6. Goka A. K., Rolston D. D., Mathan V. I., Farthing M. J. Diagnosis of Strongyloides and hookworm infections: comparison of faecal and duodenal fluid microscopy. Trans R Soc Trop Med Hyg. 1990 Nov-Dec;84(6):829–831. doi: 10.1016/0035-9203(90)90098-y. [DOI] [PubMed] [Google Scholar]
  7. Hall A., Nahar Q. Albendazole and infections with Ascaris lumbricoides and Trichuris trichiura in children in Bangladesh. Trans R Soc Trop Med Hyg. 1994 Jan-Feb;88(1):110–112. doi: 10.1016/0035-9203(94)90525-8. [DOI] [PubMed] [Google Scholar]
  8. JONES C. A., ABADIE S. H. Studies in human strongyloidiasis. II. A comparison of the efficiency of diagnosis by examination of feces and duodenal fluid. Am J Clin Pathol. 1954 Oct;24(10):1154–1158. doi: 10.1093/ajcp/24.10.1154. [DOI] [PubMed] [Google Scholar]
  9. JONES C. A. Clinical studies in human strongyloidiasis. I Semeiology. Gastroenterology. 1950 Dec;16(4):743–756. [PubMed] [Google Scholar]
  10. LIMA J. P., DELGADO P. G. Diagnosis of strongyloidiasis: importance of Baermann's method. Am J Dig Dis. 1961 Sep;6:899–904. doi: 10.1007/BF02231086. [DOI] [PubMed] [Google Scholar]
  11. Liu L. X., Weller P. F. Strongyloidiasis and other intestinal nematode infections. Infect Dis Clin North Am. 1993 Sep;7(3):655–682. [PubMed] [Google Scholar]
  12. Martirani I., Rodrigues L. D. Ensaio clínico com o cambendazole, uma nova droga na terapeutica anti-helmíntica (nota prévia) Rev Inst Med Trop Sao Paulo. 1976 Jan-Feb;18(1):71–75. [PubMed] [Google Scholar]
  13. Mojon M., Nielsen P. B. Treatment of strongyloides stercoralis with albendazole. A cure rate of 86 per cent. Zentralbl Bakteriol Mikrobiol Hyg A. 1987 Mar;263(4):619–624. doi: 10.1016/s0176-6724(87)80208-0. [DOI] [PubMed] [Google Scholar]
  14. Neva F. A., Gam A. A., Burke J. Comparison of larval antigens in an enzyme-linked immunosorbent assay for strongyloidiasis in humans. J Infect Dis. 1981 Nov;144(5):427–432. doi: 10.1093/infdis/144.5.427. [DOI] [PubMed] [Google Scholar]
  15. Nielsen P. B., Mojon M. Improved diagnosis of strongyloides stercoralis by seven consecutive stool specimens. Zentralbl Bakteriol Mikrobiol Hyg A. 1987 Mar;263(4):616–618. doi: 10.1016/s0176-6724(87)80207-9. [DOI] [PubMed] [Google Scholar]
  16. Pelletier L. L., Jr, Baker C. B., Gam A. A., Nutman T. B., Neva F. A. Diagnosis and evaluation of treatment of chronic strongyloidiasis in ex-prisoners of war. J Infect Dis. 1988 Mar;157(3):573–576. doi: 10.1093/infdis/157.3.573. [DOI] [PubMed] [Google Scholar]
  17. Sato Y., Kobayashi J., Toma H., Shiroma Y. Efficacy of stool examination for detection of Strongyloides infection. Am J Trop Med Hyg. 1995 Sep;53(3):248–250. doi: 10.4269/ajtmh.1995.53.248. [DOI] [PubMed] [Google Scholar]
  18. de Kaminsky R. G. Evaluation of three methods for laboratory diagnosis of Strongyloides stercoralis infection. J Parasitol. 1993 Apr;79(2):277–280. [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES